[1] |
HAO Xiao, ZHAO Mei, WANG Wenjing, ZHANG Feifei, LIU Huiliang, DANG Yi, LI Shuren, QI Xiaoyong.
Application of sodium-glucose cotransporter 2 inhibitors in acute myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 824-831.
|
[2] |
QIAN Jin, WANG Fengyan.
Influence factors of serum NT-proBNP level in elderly patients with acute myocardial infarction after PCI and its influence on short-term prognosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 658-665.
|
[3] |
ZHAO Lu, LI Fuyong, WEN Binhong, LI Daowei.
Effects of stains on hyperlipidemia and pain relieve of patients with chronic migraine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 671-675.
|
[4] |
PENG Yong, FAN Jianfeng, XIONG Xuhua, XIAO Dongping, GAO Zhaobo, ZHENG Chunhua.
Effect of iron dextran dispersible tablets on heart failure patients with iron deficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 178-183.
|
[5] |
CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke.
Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092.
|
[6] |
YANG Sheng, WANG Deguo.
Effects of sakubatril valsartan combined with dagliflozin in the treatment of patients with HFrEF and the effect on serum cTnⅠ and BNP levels
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1010-1015.
|
[7] |
ZENG Xiaofan, XU Yiqi, LIU Shu, WU Qian, LI Zibao, HE Junjun, JIN Yuelong, ZHAO Yongli, HE Chunling, GAO Jialin.
Retrospectively analysis of the effect of low-dose aspirin on primary prevention of non-fatal myocardial infarction and cerebral infarction in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 665-671.
|
[8] |
CHEN Xi, LI Yongjun.
Effects of Chinese patent medicine for activating blood circulation on cardiac repair after myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 680-688.
|
[9] |
PENG Juan, FAN Linlin, LI Ranyi, LI Xiaoyu, LV Qianzhou, ZOU Yunzeng.
Progress of pharmacotherapy for heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 373-381.
|
[10] |
LIU Ping, QIU Bo, WU Huizhen.
Pharmacology and clinical evaluation of vericiguat in the treatment of heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 212-218.
|
[11] |
YANG Yongkang, LI Jing, RAO Tingcai, ZHANG Junyan.
Hyperoside ameliorates the injury of heart and thoracic aorta in mice with myocardial infarction by regulating autophagy pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 601-608.
|
[12] |
XU Yonghua, SHI Xianghong.
Analysis of the efficacy of torasemide combined with levocarnitine in the treatment of chronic heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 647-652.
|
[13] |
WANG Fengling, MENG Xiangyun, CHEN Zhengxu, CAO Rongjuan, HE Zhengmin, YE Xi, WANG Cong, LI Qi.
Analysis on genetic polymorphism of SLCO1B1 and ApoE in patients with cardiovascular diseases of Han nationality in Anhui area and its clinical significance for individualized use of statins
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 40-48.
|
[14] |
CHEN Lifang, WANG Bo, WANG Weirong.
Research advances of histone deacetylase 3 in cardiovascular diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 88-97.
|
[15] |
ZHAO Wei, WU Youyang, LIN Cong, HUANG Shiwei, CHEN Hao, JIANG Wenbing.
Effects of pterostilbene on myocardial function, myocardial fibrosis and inflammatory response in rats with acute myocardial infarction and on Notch1/eIF3a signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 498-504.
|